Key statistics
On Thursday, Eledon Pharmaceuticals Inc (2TK:DEU) closed at 3.18, 51.43% above the 52 week low of 2.10 set on Oct 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.32 |
---|---|
High | 3.32 |
Low | 3.16 |
Bid | 3.16 |
Offer | 3.36 |
Previous close | 3.24 |
Average volume | 15.00 |
---|---|
Shares outstanding | 59.88m |
Free float | 59.71m |
P/E (TTM) | -- |
Market cap | 224.56m USD |
EPS (TTM) | -0.21 USD |
Data delayed at least 15 minutes, as of Jul 17 2025.
More ▼
Announcements
- Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
- Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
- Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
- Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
- Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
- Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
- Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
- Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
- Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
- Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
More ▼